IT1299201B1 - Fibroblasti modificati geneticamente e loro uso - Google Patents
Fibroblasti modificati geneticamente e loro usoInfo
- Publication number
- IT1299201B1 IT1299201B1 IT98MI001004A ITMI981004A IT1299201B1 IT 1299201 B1 IT1299201 B1 IT 1299201B1 IT 98MI001004 A IT98MI001004 A IT 98MI001004A IT MI981004 A ITMI981004 A IT MI981004A IT 1299201 B1 IT1299201 B1 IT 1299201B1
- Authority
- IT
- Italy
- Prior art keywords
- genetically modified
- modified fibroblasts
- fibroblasts
- genetically
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT98MI001004A IT1299201B1 (it) | 1998-05-08 | 1998-05-08 | Fibroblasti modificati geneticamente e loro uso |
PCT/EP1999/003075 WO1999058646A1 (en) | 1998-05-08 | 1999-05-05 | Genetically-modified fibroblasts and the use thereof |
EP99923531A EP1084232B1 (en) | 1998-05-08 | 1999-05-05 | Genetically-modified fibroblasts and the use thereof |
JP2000548438A JP2002514409A (ja) | 1998-05-08 | 1999-05-05 | 遺伝的に改変された繊維芽細胞及びその使用 |
AU40372/99A AU4037299A (en) | 1998-05-08 | 1999-05-05 | Genetically-modified fibroblasts and the use thereof |
AT99923531T ATE265526T1 (de) | 1998-05-08 | 1999-05-05 | Genetisch veränderte fibroblasten und ihre verwendung |
CA002331826A CA2331826A1 (en) | 1998-05-08 | 1999-05-05 | Genetically-modified fibroblasts and the use thereof |
DE69916829T DE69916829D1 (de) | 1998-05-08 | 1999-05-05 | Genetisch veränderte fibroblasten und ihre verwendung |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT98MI001004A IT1299201B1 (it) | 1998-05-08 | 1998-05-08 | Fibroblasti modificati geneticamente e loro uso |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI981004A1 ITMI981004A1 (it) | 1999-11-08 |
IT1299201B1 true IT1299201B1 (it) | 2000-02-29 |
Family
ID=11379982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT98MI001004A IT1299201B1 (it) | 1998-05-08 | 1998-05-08 | Fibroblasti modificati geneticamente e loro uso |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1084232B1 (it) |
JP (1) | JP2002514409A (it) |
AT (1) | ATE265526T1 (it) |
AU (1) | AU4037299A (it) |
CA (1) | CA2331826A1 (it) |
DE (1) | DE69916829D1 (it) |
IT (1) | IT1299201B1 (it) |
WO (1) | WO1999058646A1 (it) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6492169B1 (en) | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
EP1157999A1 (en) * | 2000-05-24 | 2001-11-28 | Introgene B.V. | Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof |
JP2010148440A (ja) * | 2008-12-25 | 2010-07-08 | Japan Health Science Foundation | 組換えアデノウイルス迅速構築システム |
US20200338134A1 (en) * | 2019-04-26 | 2020-10-29 | Cleveland State University | Muscle treatment method using myod mutant |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219740A (en) * | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
WO1995012979A1 (en) * | 1993-11-08 | 1995-05-18 | The University Of Southern California | Compositions and methods for transduction of cells |
GB9419048D0 (en) * | 1994-09-20 | 1994-11-09 | Watt Diana J | Treatment of muscular disorders |
ATE356199T1 (de) * | 1996-10-18 | 2007-03-15 | Univ Laval | Verfahren zur in vitro vorbehandlung von myoblasten in der transplantation |
-
1998
- 1998-05-08 IT IT98MI001004A patent/IT1299201B1/it active IP Right Grant
-
1999
- 1999-05-05 AU AU40372/99A patent/AU4037299A/en not_active Abandoned
- 1999-05-05 CA CA002331826A patent/CA2331826A1/en not_active Abandoned
- 1999-05-05 DE DE69916829T patent/DE69916829D1/de not_active Expired - Fee Related
- 1999-05-05 JP JP2000548438A patent/JP2002514409A/ja active Pending
- 1999-05-05 AT AT99923531T patent/ATE265526T1/de not_active IP Right Cessation
- 1999-05-05 EP EP99923531A patent/EP1084232B1/en not_active Expired - Lifetime
- 1999-05-05 WO PCT/EP1999/003075 patent/WO1999058646A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2331826A1 (en) | 1999-11-18 |
EP1084232B1 (en) | 2004-04-28 |
ATE265526T1 (de) | 2004-05-15 |
JP2002514409A (ja) | 2002-05-21 |
AU4037299A (en) | 1999-11-29 |
ITMI981004A1 (it) | 1999-11-08 |
WO1999058646A1 (en) | 1999-11-18 |
DE69916829D1 (de) | 2004-06-03 |
EP1084232A1 (en) | 2001-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0207775A (pt) | Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização | |
DE58906718D1 (de) | Kunststeine, verfahren zur herstellung und verwendung derselben. | |
AU2002343557A1 (en) | Substituted aryl 1,4-pyrazine derivatives | |
KR970001343A (ko) | 나프탈렌 유도체,그의 제조 방법,및그의 중간체 | |
DE60010098D1 (de) | 28-epirapaloge | |
MY130489A (en) | Substituted aryl 1, 4-pyrazine derivatives | |
DE59603216D1 (de) | Esterquats und ihre Verwendung zur Herstellung von oberflächenaktiven Mitteln, insbesondere zur Haar- und Körperpflege | |
ATE247099T1 (de) | Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel | |
DE3585953D1 (de) | Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine. | |
DE69901177T2 (de) | Platinkomplex, dessen herstellung und dessen therapeutische verwendung | |
DE69623472D1 (de) | Derivate von dolastatin, dreen herstellung un verwendung | |
EP1616942A3 (en) | Patched genes and their use | |
NO971341D0 (no) | Promoter for reseptor tyrosinkinase TIE | |
ATE405662T1 (de) | Verfahren zur herstellung rekombinanter adenovirus-genome | |
DE69131381T2 (de) | Strukturproteine durch künstliche gene | |
DE69312408T2 (de) | Harte, gegen Verschleiss widerstandsfähige Beschichtung und Verfahren zur Herstellung derselben | |
DE59808444D1 (de) | Weichmagnetischer, formbarer verbundwerkstoff und verfahren zu dessen herstellung | |
DE69626816D1 (de) | Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren | |
IT1299201B1 (it) | Fibroblasti modificati geneticamente e loro uso | |
FI953534A (fi) | Menetelmä sellaisten yksölöiden tunnistamiseksi ja hoitamiseksi, joilla on HLA-C-klooni 10/MAGE-1:tä ekspressoivia syöpäsoluja | |
DE68917154T2 (de) | C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung. | |
DE69130845D1 (de) | HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung | |
TW200503717A (en) | Substituted 1,4-pyrazine derivatives | |
FI960706A0 (fi) | Uusi proteiini ja menetelmiä proteiinin valmistamiseksi | |
DE69611303T2 (de) | Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |